This review highlights controversies in carotid artery disease guidelines, particularly regarding the timing of intervention after TIA/minor stroke and the treatment of asymptomatic patients.
Answers are grounded in this paper and cite their sources.
Guideline discrepancies warrant caution in average-risk carotid stenting; leaves open optimal post-TIA timing and asymptomatic management.
Year 2011 sees the publication of U.S. guidelines that recommend expanding indications for carotid artery stenting into "average-risk" patients, whereas guidelines from Australia/New Zealand largely do not. This article reviews the status of invasive treatment of carotid disease and highlights 2 controversial issues that were not really addressed in these guidelines: (1) a lack of emphasis on the importance of intervening rapidly after transient ischemic attack/minor stroke; and (2) why continue to recommend that only "highly selected" asymptomatic patients should undergo intervention when virtually no-one pays any attention?
No takes yet. Share an insight, caveat, or question.
A.R. Naylor (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: